People deserve
better answers.

What We Do

genetics-icon
Genetics

Innovative solutions that empower researchers, from fragile X syndrome to CFTR to SMN1/2.

Learn more about our AmplideX Genetics testing kits
oncology-icon
Oncology

Solving complex molecular challenges, from chronic myeloid leukemia (CML) to solid tumors.

Learn more about our QuantideX BCR-ABL kits
cdx-icon
MolecularDx Controls

The gold standard for molecular quality controls.

Learn more about our custom molecular controls
Spotlight

Asuragen to showcase innovative diagnostics lab solutions at AMP 2022 Conference

At AMP, Asuragen will host two educational workshops, one focused on a streamlined workflow and equitable testing approach for genetic testing and the other on rapid development of molecular controls for emerging diseases. Scientists from the company will also present several posters with updates about clinical tests based on nanopore sequencing technology, molecular controls for SARS-CoV-2 testing, and more.

Learn more about Asuragen at AMP 2022
Spotlight

Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis

CFTR testing kit with streamlined workflow delivers reliable results in less than five hours

Learn More about our CFTR testing kit
Spotlight

Asuragen Announces Launch of AmplideX® PCR/CE SMN1/2 Plus Kit

The AmplideX® PCR/CE SMN1/2 Plus Kit is a clinical research tool providing the most comprehensive analysis of SMN1 and SMN2 currently available from a commercial kit.

Learn more about our SMN1/2 Plus kit
Spotlight

Asuragen Expands Genetic Portfolio with Launch of AmplideX® PCR/CE HTT Kit

The AmplideX® PCR/CE HTT Kit is a simple, robust, and reliable test for the detection of CAG trinucleotide repeats within the HTT gene, aberrations which are associated with the development of Huntington’s Disease (HD).

Read more about our HTT kit

The Latest from Asuragen

Video Placeholder
Behind the Mystery of Fragile X Syndrome

Fragile X syndrome is a genetic disorder that is caused by a gene mutation on the X chromosome. Symptoms frequently include developmental delays, intellectual disabilities, and behavioral issues. Carriers for Fragile X don’t have Fragile X syndrome; however, they do have an increased chance of certain medical issues. Testing for Fragile X syndrome is important, especially for women who are pregnant or plan to become pregnant. Learn more about Fragile X from Ilana Garber, who shares her and her son Yaron’s journey with Fragile X syndrome as well as from Dr. Tamar Goldwaser, an OBGYN and medical geneticist.

Request To See Full Video

News
BIO-TECHNE AND OXFORD NANOPORE TECHNOLOGIES PARTNER TO BRING INNOVATIVE REPRODUCTIVE HEALTH AND CARRIER SCREENING SOLUTIONS TO THE MARKET
News
ASURAGEN TO SHOWCASE INNOVATIVE DIAGNOSTIC LAB SOLUTIONS AT AMP 2022 CONFERENCE
News
Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis
News
Asuragen Partners with Wave Life Sciences to Develop Companion Diagnostics for Huntington’s Disease
Back To
Top